Cargando…

Protective Role of L-3-n-Butylphthalide in Cognitive Function and Dysthymic Disorders in Mouse With Chronic Epilepsy

Epilepsy is a common neurological disease with recurrent seizures and neurobehavioral comorbidities, including cognitive impairment and psychiatric disorders. Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Xiaowen, Rong, Zhouyi, Li, Yanfang, Wang, Xintian, Cheng, Baoying, Cheng, Yiyun, Luo, Haijuan, Ti, Yue, Huang, Xiaohua, Liu, Zhaoji, Zhang, Yun-wu, Zheng, Weihong, Zheng, Honghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051017/ https://www.ncbi.nlm.nih.gov/pubmed/30050437 http://dx.doi.org/10.3389/fphar.2018.00734

Ejemplares similares

Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
por: Cheng, Baoying, et al.
Publicado: (2021)

DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation
por: Han, Bingjiang, et al.
Publicado: (2021)

Butylphthalide Inhibits Autophagy and Promotes Multiterritory Perforator Flap Survival
por: Li, Baolong, et al.
Publicado: (2021)

N-Butylphthalide Improves Cognitive Function in Rats after Carbon Monoxide Poisoning
por: Bi, Ming-Jun, et al.
Publicado: (2017)

Use of aripiprazole in dysthymic disorders. Purposely a case
por: Ogando Portilla, N., et al.
Publicado: (2023)

Cognitive Vulnerability in Patients with Generalized Anxiety Disorder, Dysthymic Disorder and Normal Individuals
por: Al-Ghorabaie, Fateme Moin, et al.
Publicado: (2016)

An open treatment trial of duloxetine in elderly patients with dysthymic disorder
por: Kerner, Nancy, et al.
Publicado: (2014)

DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
por: Zhang, Hui, et al.
Publicado: (2023)

N-Butylphthalide Alleviates Blood–Brain Barrier Impairment in Rats Exposed to Carbon Monoxide
por: Bi, Mingjun, et al.
Publicado: (2016)

Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Fan, Xueming, et al.
Publicado: (2022)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

Relationship of Quality of Life with Disability Grade in Obsessive Compulsive Disorder and Dysthymic Disorder
por: Roopesh Gopal, NV, et al.
Publicado: (2014)

PS211. Fear conditioning induced by interpersonal conflicts in patients with dysthymic disorder
por: Tada, Mitsuhiro, et al.
Publicado: (2016)

Comparison of the Effect of Mindfulness-based Cognitive Therapy Accompanied by Pharmacotherapy With Pharmacotherapy Alone in Treating Dysthymic Patients
por: Hamidian, Sajedeh, et al.
Publicado: (2013)

Effect of Dl-3-n-butylphthalide on mitochondrial Cox7c in models of cerebral ischemia/reperfusion injury
por: Jia, Jingjing, et al.
Publicado: (2023)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
por: Wang, Huan, et al.
Publicado: (2022)

Dl-3-N-Butylphthalide Promotes Angiogenesis in an Optimized Model of Transient Ischemic Attack in C57BL/6 Mice
por: Wang, Jiahui, et al.
Publicado: (2021)

Compensatory Mechanisms Modulate the Neuronal Excitability in a Kainic Acid-Induced Epilepsy Mouse Model
por: Pan, Gaojie, et al.
Publicado: (2018)

Four Cases of Dysthymic Disorder and General Malaise Successfully Treated with Traditional Herbal (Kampo) Medicines: Kamiuntanto
por: Kogure, Toshiaki, et al.
Publicado: (2010)

TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
por: Zheng, Honghua, et al.
Publicado: (2018)

Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study
por: Liu, Xintian, et al.
Publicado: (2023)

Role of Butylphthalide in Immunity and Inflammation: Butylphthalide May Be a Potential Therapy for Anti-Inflammation and Immunoregulation
por: Zhang, Yiliu, et al.
Publicado: (2022)

Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models
por: Yang, Qin, et al.
Publicado: (2017)

Dl-NBP (Dl-3-N-Butylphthalide) Treatment Promotes Neurological Functional Recovery Accompanied by the Upregulation of White Matter Integrity and HIF-1α/VEGF/Notch/Dll4 Expression
por: Wang, Yanping, et al.
Publicado: (2020)

Controlled randomized clinical trial of spirituality integrated psychotherapy, cognitive-behavioral therapy and medication intervention on depressive symptoms and dysfunctional attitudes in patients with dysthymic disorder
por: Ebrahimi, Amrollah, et al.
Publicado: (2013)

Apelin receptor inhibition in ischemia-reperfused mouse hearts protected by endogenous n-3 polyunsaturated fatty acids
por: Zheng, Shuang, et al.
Publicado: (2023)

Metformin Protects Against Diabetes-Induced Cognitive Dysfunction by Inhibiting Mitochondrial Fission Protein DRP1
por: Hu, Yan, et al.
Publicado: (2022)

Application and prospects of butylphthalide for the treatment of neurologic diseases
por: Chen, Xi-Qian, et al.
Publicado: (2019)

Identification of a Novel Hemizygous SQSTM1 Nonsense Mutation in Atypical Behavioral Variant Frontotemporal Dementia
por: Sun, Lin, et al.
Publicado: (2018)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

3-n-butylphthalide exerts neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke
por: Chen, Ningyuan, et al.
Publicado: (2018)

DL-3-n-butylphthalide promotes hippocampal neurogenesis and reduces mossy fiber sprouting in chronic temporal lobe epilepsy rats
por: Zhao, Shanshan, et al.
Publicado: (2022)

Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism
por: He, Li-Ying, et al.
Publicado: (2021)

Neuroprotective mechanisms of 3-n-butylphthalide in neurodegenerative diseases
por: Luo, Rixin, et al.
Publicado: (2019)

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
por: Chen, Yajing, et al.
Publicado: (2019)

Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy
por: Shi, Nan-Rui, et al.
Publicado: (2023)

Necrostatin-1 Attenuates Trauma-Induced Mouse Osteoarthritis and IL-1β Induced Apoptosis via HMGB1/TLR4/SDF-1 in Primary Mouse Chondrocytes
por: Liang, Shuang, et al.
Publicado: (2018)

Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach
por: Kundap, Uday P., et al.
Publicado: (2017)

Ursolic Acid Protects Neurons in Temporal Lobe Epilepsy and Cognitive Impairment by Repressing Inflammation and Oxidation
por: Liu, Kun-mei, et al.
Publicado: (2022)

Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
por: Ding, Zhi-Ming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0kdeplcc2kdbh43jsi1fmuh68q